Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kazia Therapeutics (KZIA) Operating Expenses (2016 - 2018)

Kazia Therapeutics (KZIA) posted Operating Expenses of $73.89 for Q4 2018, down 99.95% on a QoQ basis from $156425.5 in Q4 2017, and down 99.95% year-over-year from $156425.5 in Q4 2017.

Kazia Therapeutics (KZIA) has 3 years of Operating Expenses data on file, last reported at $73.89 in Q4 2018.

  • In Q4 2018, Operating Expenses fell 99.95% year-over-year to $73.89; the TTM figure through Jun 2020 stood at $73.89 (down 99.95% YoY), while the FY2025 annual figure was $10.3 million, down 49.61% from the prior year.
  • Operating Expenses retreated to $73.89 in Q4 2018, from $156425.5 in the prior quarter.
  • Across five years, Operating Expenses topped out at $156425.5 in Q4 2017 and bottomed at $73.89 in Q4 2018.
  • A 3-year average of $64628.1 and a median of $37384.9 in 2016 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2017 — Operating Expenses jumped 318.42% — and 2018, when it sank 99.95%.
  • Year by year, Operating Expenses stood at $37384.9 in 2016, then jumped by 318.42% to $156425.5 in 2017, then sank by 99.95% to $73.89 in 2018.
  • The last three Operating Expenses figures came in at $73.89 (Q4 2018), $156425.5 (Q4 2017), and $37384.9 (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 73.89
Dec 31, 2017 156,425.52
Dec 31, 2016 37,384.89